Overview

Oral Naltrexone In Pediatric Eating Disorders

Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effectiveness of oral naltrexone tablets in pediatric and adolescent eating disorders, in particular anorexia nervosa and bulimia nervosa, as compared to placebo. Study participants will be patients in a partial hospitalization program or intensive outpatient program for eating disorder.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Rosemary Claire Roden
Collaborator:
Children's Miracle Network
Treatments:
Naltrexone